Pediatric cancer research: Surviving COVID‐19
Jeffery J. Auletta(Nationwide Children's Hospital), Timothy P. Cripe(Nationwide Children's Hospital), J. Agin(CHDI Foundation), Scott R. Kennedy(University of Washington), Pamela Kearns(National Institute for Health and Care Research), Kristi McKay(Solving Kids' Cancer), Mark W. Kieran(Children Cancer Hospital), Peter C. Adamson(University College London), Donna Ludwinski(Solving Kids' Cancer), Carol J. Thiele(National Cancer Institute), Leona Knox(London Cancer), Pia Rhiner(Solving Kids' Cancer)
Cited by 34
Related Papers
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
|Nature Nanotechnology|2014|580
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
The cloche and spadetail Genes Differentially Affect Hematopoiesis and Vasculogenesis
|Developmental Biology|1998|512
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
|Nature Genetics|2014|464
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
|PLoS ONE|2009|433